Clinical trial NCT05134766 - References

Acute Upper Respiratory Tract Infection — Retrospective Evaluation of Clinical, Virological and Serological Data in Patients With Mild Acute Upper Respiratory Tract Infections

Citation(s)

•   Costa R, Bueno F, Albert E, Torres I, Carbonell-Sahuquillo S, Barrés-Fernández A, Sánchez D, Padrón C, Colomina J, Lázaro Carreño MI, Bretón-Martínez JR, Martínez-Costa C, Navarro D
  Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults. Clin Microbiol Infect. 2021 Aug 9. pii: S1198-743X(21)00438-9. doi: 10.1016/j.cmi.2021.08.001. [Epub ahead of print]
•   Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, Altaf N, Zahid M, Ujjan ID, Nigar R, Khushk MI, Phulpoto M, Lail A, Devrajani BR, Ahmed S
  Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. Int J Gen Med. 2021 Jun 8;14:2359-2366. doi: 10.2147/IJGM.S318720. eCollection 2021.
•   Droebner K, Ehrhardt C, Poetter A, Ludwig S, Planz O
  CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 2007 Oct;76(1):1-10. Epub 2007 May 15.
•   El-Anwar MW, Elzayat S, Fouad YA
  ENT manifestation in COVID-19 patients. Auris Nasus Larynx. 2020 Aug;47(4):559-564. doi: 10.1016/j.anl.2020.06.003. Epub 2020 Jun 15. Review.
•   Goc A, Sumera W, Rath M, Niedzwiecki A
  Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions. PLoS One. 2021 Jun 17;16(6):e0253489. doi: 10.1371/journal.pone.0253489. eCollection 2021.
•   Ra SH, Lim JS, Kim GU, Kim MJ, Jung J, Kim SH
  Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax. 2021 Jan;76(1):61-63. doi: 10.1136/thoraxjnl-2020-215042. Epub 2020 Sep 22. Erratum in: Thorax. 2021 May;76(5):e3.
•   Rosas-Salazar C, Kimura KS, Shilts MH, Strickland BA, Freeman MH, Wessinger BC, Gupta V, Brown HM, Rajagopala SV, Turner JH, Das SR
  SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome. J Allergy Clin Immunol. 2021 Apr;147(4):1226-1233.e2. doi: 10.1016/j.jaci.2021.02.001. Epub 2021 Feb 9.
•   Valle C, Martin B, Touret F, Shannon A, Canard B, Guillemot JC, Coutard B, Decroly E
  Drugs against SARS-CoV-2: What do we know about their mode of action? Rev Med Virol. 2020 Nov;30(6):1-10. doi: 10.1002/rmv.2143. Epub 2020 Aug 11. Review.

Retrospective Evaluation of Clinical, Virological and Serological Data in Patients With Mild Acute Upper Respiratory Tract Infections

Details for clinical trial NCT05134766